2,4-thiazolidinedione Completed Phase 1 Trials for Resistance, Insulin / Obesity / Syndrome, Metabolic

Indications	Status	Purpose	Phase
DBCOND0128173 (Resistance, Insulin) DBCOND0015947 (Obesity) DBCOND0136716 (Syndrome, Metabolic)	Completed	Not Available	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00285844	Integrating the Genetic and Metabolic Faces of Obesity	2,4-thiazolidinedione (DB11898)